Opens new tech and innovation site in Hyderabad
 
Amgen announced the opening of Amgen India, its new technology and innovation site in Hyderabad. The company plans to invest $200 million through 2025, with additional sustained investments planned over the coming years. The site will accelerate Amgen’s digital capabilities through artificial intelligence and data science to further advance its pipeline of medicines while creating significant opportunities for local talent.

Amgen India is located in HITEC City, occupying approximately 524,000 square feet in RMZ Tower 110 of Spire and Tower 20 of Nexity. Robert AC Bradway, Chairman and CEO, Amgen, was joined by Sri Anumula Revanth Reddy, Chief Minister, Telangana and D Sridhar Babu, Minister of IT, Electronics & Communications, Industries & Commerce, and Legislative Affairs, Government of Telangana, at the site. 
 
 
"Amgen India is a reflection of our growth ambitions as well as an extension of our commitment to global health,” said Som Chattopadhyay, National Executive for India, Amgen. “We are excited to contribute to the dynamic global biotech ecosystem from India and welcome the incredible talent pool the country offers.”

Naveen Gullapalli, MD, Amgen India, emphasised the strategic value of the new site for the company’s global operations, stating, "Hyderabad is rapidly emerging as a global technology hub, and our new site is positioned at the heart of this landscape. Talent at Amgen India will drive global projects and initiatives, leveraging expertise across our global sites. Amgen India employees will bring bold, innovative thinking to help shape the future of global biotechnology from India.”